Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy

VirusDisease

Volumn 25, Issue 1, 2014, Pages 18-25

  Bayry, Jagadeesh ^a  

^a INSERM   (France)

Author keywords

Adjuvant; CCL17; CCL22; CCR4; Regulatory T cells; Tregs; Vaccine

Indexed keywords

CHEMOKINE RECEPTOR CCR4 ANTAGONIST; IMMUNOLOGICAL ADJUVANT; VIRUS VACCINE;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; DRUG EFFICACY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE FUNCTION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION; VACCINATION; VIRUS INFECTION;

EID: 84941115750     PISSN: 23473584     EISSN: 23473517     Source Type: Journal    
DOI: 10.1007/s13337-013-0187-3     Document Type: Review

References (68)

1. Aimanianda V, Haensler J, Lacroix-Desmazes S, Kaveri SV, Bayry J. Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci. 2009;30:287–95.
2. Amoah S, Holbrook BC, Yammani RD, Alexander-Miller MA. High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion. J Immunol. 2013;190:5020–9.
3. Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J. Surveillance of antigen-presenting cells by CD4 + CD25 + regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol. 2009;174:1575–87.
4. Bayry J, Triebel F, Kaveri SV, Tough DF. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4 + CD25 + regulatory T cells. J Immunol. 2007;178:4184–93.
5. Bayry J, Kaveri SV, Tough DF. Do activated human dendritic cells diminish the suppressive functions of CD4 +, CD25 + regulatory T cells? Arthritis Rheum. 2007;56:3874–6.
6. Bayry J, Siberil S, Triebel F, Tough DF, Kaveri SV. Rescuing CD4 + CD25 + regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. Drug Discov Today. 2007;12:548–52.
7. Bayry J, Tchilian EZ, Davies MN, Forbes EK, Draper SJ, Kaveri SV, Hill AV, Kazatchkine MD, Beverley PC, Flower DR, Tough DF. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci USA. 2008;105:10221–6.
8. Bayry J, Flower DR, Tough DF, Kaveri SV. From ‘perfect mix’ to ‘potion magique’-regulatory T cells and anti-inflammatory cytokines as adjuvant targets. Nat Rev Microbiol. 2008;6:C1.
9. Brincks EL, Roberts AD, Cookenham T, Sell S, Kohlmeier JE, Blackman MA, Woodland DL. Antigen-specific memory regulatory CD4 + Foxp3 + T cells control memory responses to influenza virus infection. J Immunol. 2013;190:3438–46.
10. Cederbom L, Hall H, Ivars F. CD4 + CD25 + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000;30:1538–43.
11. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–9.
12. Davies MN, Bayry J, Tchilian EZ, Vani J, Shaila MS, Forbes EK, Draper SJ, Beverley PC, Tough DF, Flower DR. Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors. PLoS One. 2009;4:e8084.
13. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4:1206–12.
14. Fulton RB, Meyerholz DK, Varga SM. Foxp3 + CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol. 2010;185:2382–92.
15. Garner-Spitzer E, Wagner A, Paulke-Korinek M, Kollaritsch H, Heinz FX, Redlberger-Fritz M, Stiasny K, Fischer GF, Kundi M, Wiedermann U. Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10. J Immunol. 2013;191:2426–36.
16. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589–601.
17. Hegde NR, Kaveri SV, Bayry J. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today. 2011;16:1061–8.
18. Houot R, Perrot I, Garcia E, Durand I, Lebecque S. Human CD4 + CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J Immunol. 2006;176:5293–8.
19. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D’Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194:847–53.
20. Kanneganti TD. Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol. 2010;10:688–98.
21. Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch DH, Belkaid Y, Drexler I, Germain RN. Regulatory T cells selectively control CD8 + T cell effector pool size via IL-2 restriction. J Immunol. 2011;187:3186–97.
22. Kim B, Feng N, Narváez CF, He XS, Eo SK, Lim CW, Greenberg HB. The influence of CD4 + CD25 + Foxp3 + regulatory T cells on the immune response to rotavirus infection. Vaccine. 2008;26:5601–11.
23. Kondo Y, Ueno Y, Kobayashi K, Kakazu E, Shiina M, Inoue J, Tamai K, Wakui Y, Tanaka Y, Ninomiya M, Obara N, Fukushima K, Ishii M, Kobayashi T, Niitsuma H, Kon S, Shimosegawa T. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes. J Infect Dis. 2010;202:202–13.
24. Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ. CD4 + CD25 + natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol. 2010;84:8790–8.
25. Li J, Chen H, Wu N, Fan D, Liang G, Gao N, An J. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice. Vaccine. 2013;31:4136–42.
26. Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L, Flores M, Li N, Schweighoffer E, Greenberg S, Tybulewicz V, Vignali D, Clynes R. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol. 2008;180:5916–26.
27. Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C. Cutting Edge: CD25 + regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol. 2008;181:4447–51.
28. Lühn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT, le Thao TT, Van Ngoc T, Dung NM, Wills B, Farrar J, McMichael AJ, Dong T, Rowland-Jones S. Increased frequencies of CD4 + CD25(high) regulatory T cells in acute dengue infection. J Exp Med. 2007;204:979–85.
29. Mahnke K, Ring S, Johnson TS, Schallenberg S, Schönfeld K, Storn V, Bedke T, Enk AH. Induction of immunosuppressive functions of dendritic cells in vivo by CD4 + CD25 + regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol. 2007;37:2117–26.
30. Maizels RM, Smith KA. Regulatory T cells in infection. Adv Immunol. 2011;112:73–136.
31. Miller MM, Fogle JE, Tompkins MB. Infection with feline immunodeficiency virus directly activates CD4 + CD25 + T regulatory cells. J Virol. 2013;87:9373–8.
32. Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: human CD4 + CD25 + T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol. 2004;172:4676–80.
33. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity. 2009;30:899–911.
34. Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol. 2005;175:7264–73.
35. Navarrete AM, Meslier Y, Teyssandier M, André S, Delignat S, Triebel F, Kaveri SV, Lacroix-Desmazes S, Bayry J. CD4 + CD25 + regulatory T cells modulate human dendritic cell chemokines via multiple mechanisms. Arthritis Rheum. 2009;60:2848–9.
36. Navarrete AM, Delignat S, Teillaud JL, Kaveri SV, Lacroix-Desmazes S, Bayry J. CD4 + CD25 + regulatory T cell-mediated changes in the expression of endocytic receptors and endocytosis process of human dendritic cells. Vaccine. 2011;29:2649–52.
37. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA. 2008;105:10113–8.
38. Othy S, Topcu S, Kaveri SV, Bayry J. Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2012;109:E2412–3.
39. Pere H, Montier Y, Bayry J, Quintin-Colonna F, Merillon N, Dransart E, Badoual C, Gey A, Ravel P, Marcheteau E, Batteux F, Sandoval F, Adotevi O, Chiu C, Garcia S, Tanchot C, Lone YC, Ferreira LC, Nelson BH, Hanahan D, Fridman WH, Johannes L, Tartour E. A CCR4 antagonist combined with vaccines induces antigen-specific CD8 + T cells and tumor immunity against self antigens. Blood. 2011;118:4853–62.
40. Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E. Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. Oncoimmunology. 2012;1:326–33.
41. Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol. 2011;11:865–72.
42. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275–88.
43. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.
44. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490–500.
45. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity. 2008;28:402–13.
46. Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, Verdaguer J, Santamaria P. CD40 ligation releases immature dendritic cells from the control of regulatory CD4 + CD25 + T cells. Immunity. 2003;19:877–89.
47. Shevchenko I, Karakhanova S, Soltek S, Link J, Bayry J, Werner J, Umansky V, Bazhin AV. Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer. 2013;133:98–107.
48. Surls J, Nazarov-Stoica C, Kehl M, Casares S, Brumeanu TD. Differential effect of CD4 + Foxp3 + T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine. 2010;28:7319–30.
49. Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med. 2001;194:823–32.
50. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4 + CD25 + T cells regulate virus-specific primary and memory CD8 + T cell responses. J Exp Med. 2003;198:889–901.
51. Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, Maraver A, Lafaille JJ, Dustin ML. Regulatory T cells inhibit stable contacts between CD4 + T cells and dendritic cells in vivo. J Exp Med. 2006;203:505–11.
52. Taguchi O, Takahashi T. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol. 1996;26:1608–12.
53. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006;7:83–92.
54. Tang Q, Bluestone JA. The Foxp3 + regulatory T cell: a jack of all trades, master of regulation. Nat Immunol. 2008;9:239–44.
55. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA. 2007;104:19446–51.
56. Toka FN, Suvas S, Rouse BT. CD4 + CD25 + T cells regulate vaccine-generated primary and memory CD8 + T-cell responses against herpes implex virus type 1. J Virol. 2004;78:13082–9.
57. Trandem K, Anghelina D, Zhao J, Perlman S. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol. 2010;184:4391–400.
58. Tsunemi D, Iwasaki T, Imado T, Higasa S, Kakishita E, Shirasaka T, Sano H. Relationship of CD4 + CD25 + regulatory T cells to immune status in HIV-infected patients. AIDS. 2005;19:879–86.
59. van’t Land B, Schijf M, van Esch BC, van Bergenhenegouwen J, Bastiaans J, Schouten B, Boon L, Garssen J. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine. 2010;28:5711–7.
60. Veldhoen M, Moncrieffe H, Hocking RJ, Atkins CJ, Stockinger B. Modulation of dendritic cell function by naive and regulatory CD4 + T cells. J Immunol. 2006;176:6202–10.
61. Veiga-Parga T, Suryawanshi A, Mulik S, Giménez F, Sharma S, Sparwasser T, Rouse BT. On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol. 2012;189:5924–33.
62. Vitali C, Mingozzi F, Broggi A, Barresi S, Zolezzi F, Bayry J, Raimondi G, Zanoni I, Granucci F. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood. 2012;120:1237–45.
63. Walsh KP, Mills KH. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 2013;34:521–30.
64. Wang SM, Tsai MH, Lei HY, Wang JR, Liu CC. The regulatory T cells in anti-influenza antibody response post influenza vaccination. Hum Vaccine Immunother. 2012;8:1243–9.
65. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S. CTLA-4 control over Foxp3 + regulatory T cell function. Science. 2008;322:271–5.
66. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, Anthony BA, Sverdrup FM, Head R, Kuster DJ, Ruminski P, Weiss D, Von Schack D, Bluestone JA. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 2012;209:1713–22.
67. Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM. Activated CD4 + CD25 + T cells selectively kill B lymphocytes. Blood. 2006;107:3925–32.
68. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010;28:445–89.